AAREYDRUGS (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE adds six securities to ESM Stage I effective April 30, 2026, requiring 100% margin and shift from Rolling Settlement to Trade-for-Trade … | |||||||||||||||
NSE adds six securities to ESM Stage I effective April 30, 2026, requiring 100% margin and shift from Rolling Settlement to Trade-for-Trade segment from May 4, 2026.
| |||||||||||||||
NSE announces changes to the Long-Term Additional Surveillance Measure (ASM) framework effective April 1, 2026, including stage movements … | |||||||||||||||
NSE announces changes to the Long-Term Additional Surveillance Measure (ASM) framework effective April 1, 2026, including stage movements and exclusions. Prime Focus Limited moves from Stage I to Stage II; consolidated ASM list contains securities across multiple stages.
| |||||||||||||||
NSE places 5 securities under Long-Term Additional Surveillance Measure (ASM) Stage I effective February 24, 2026, with 100% margin … | |||||||||||||||
NSE places 5 securities under Long-Term Additional Surveillance Measure (ASM) Stage I effective February 24, 2026, with 100% margin requirement applicable from February 26, 2026.
| |||||||||||||||